Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-04
DOI
10.1002/1878-0261.12790
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Translating basic science discoveries into improved outcomes for glioblastoma
- (2020) Peter B Dirks et al. CLINICAL CANCER RESEARCH
- Pan-cancer analysis of whole genomes
- (2020) NATURE
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Tumor mutational burden (TMB) standardization initiatives: Recommendations for consistent TMB assessment in clinical samples to guide immunotherapy treatment decisions
- (2019) Albrecht Stenzinger et al. GENES CHROMOSOMES & CANCER
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer
- (2019) Li Liu et al. CLINICAL CANCER RESEARCH
- Molecular targeted therapy of glioblastoma
- (2019) Emilie Le Rhun et al. CANCER TREATMENT REVIEWS
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- Longitudinal molecular trajectories of diffuse glioma in adults
- (2019) Floris P. Barthel et al. NATURE
- Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
- (2018) Sherise D Ferguson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
- (2018) Signe R Michaelsen et al. NEURO-ONCOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment
- (2018) Samuel F. Bakhoum et al. CELL
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Molecular characterization of cancers with NTRK gene fusions
- (2018) Zoran Gatalica et al. MODERN PATHOLOGY
- MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges
- (2018) Alireza Mansouri et al. NEURO-ONCOLOGY
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
- (2018) Nathalie E. Synhaeve et al. Acta Neuropathologica Communications
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Genomic diagnostics leading to the identification of a TFG-ROS1 fusion in a child with possible atypical meningioma
- (2017) Maria Rossing et al. Cancer Genetics
- The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection
- (2017) Andrea M. Muscat et al. Oncotarget
- ONC201: a new treatment option being tested clinically for recurrent glioblastoma
- (2017) Marie D. Ralff et al. Translational Cancer Research
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Trans-ethnic study design approaches for fine-mapping
- (2016) Jennifer L Asimit et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors
- (2016) Eileen Shi et al. Journal of Translational Medicine
- Successful Treatment of a Patient with Glioblastoma and a Germline POLE Mutation: Where Next?
- (2016) A. Snyder et al. Cancer Discovery
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
- (2015) Noemi Andor et al. NATURE MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Numerical chromosomal instability mediates susceptibility to radiation treatment
- (2015) Samuel F. Bakhoum et al. Nature Communications
- Chromosomal Instability Associated with Global DNA Hypomethylation is Associated with the Initiation and Progression of Esophageal Squamous Cell Carcinoma
- (2014) Hiroyuki Kawano et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling
- (2014) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography (18F-FET PET) in glioblastoma surgery
- (2012) Karl Roessler et al. NEUROLOGICAL RESEARCH
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution
- (2011) Huanying Ge et al. BIOINFORMATICS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development
- (2009) L. Hu et al. CANCER RESEARCH
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
- (2008) Sharon E. Plon et al. HUMAN MUTATION
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started